Business Wire

KAYTUS Launches MotusAI Enterprise Token Management Platform

4.6.2026 09:02:00 CEST | Business Wire | Press Release

Share

KAYTUS, a leading provider of AI infrastructure and liquid cooling solutions, today announced the launch of enterprise-grade token management capabilities within MotusAI, enabling organizations to rapidly build, deploy, and operate secure on-premises AI token platform. This pioneering infrastructure enhancement transforms traditional GPU hardware into a unified, governable, and highly efficient internal token service ecosystem. By enabling rapid private deployment, MotusAI provides enterprises with a cost-competitive foundation for accelerating the scale-up of enterprise-grade AI agents while ensuring strong data privacy.

Why Enterprises Must Build a Private Token Management Platform Now?

As enterprise AI evolves from isolated model-based tools to interconnected AI agent systems that enable deep workflow automation, tokens are emerging as the fundamental “computing currency” of the modern organization. While standard LLM queries typically involve predictable, one-off inference requests, AI agents execute complex business processes through multi-agent collaboration, iterative reasoning, and continuous tool calls. This approach chains together multiple inference steps, causing token consumption to rise unpredictably while amplifying cost and security risks across the enterprise network. Without centralized on-premises infrastructure, decentralized reliance on external APIs can create significant operational bottlenecks.

By rapidly deploying an internal token platform, enterprises gain three critical advantages:

Active Cost Control: Organizations can implement centralized token pool management to eliminate low-value or redundant calls, optimize traffic routing, and significantly reduce overall operational expenses.

Absolute Data Sovereignty: A localized, single-entry token platform ensures that sensitive corporate data and proprietary business logic remain entirely within the corporate boundary, eliminating external compliance, legal, and security risks.

Infrastructure Optimization: Enterprises can break down infrastructure silos by managing diverse open-source, commercial, and proprietary models within a unified local system, enabling developers to dynamically route tasks based on performance requirements and hardware efficiency.

Rapidly Building an Internal Token Infrastructure with MotusAI

KAYTUS removes complex deployment and development barriers, enabling enterprises to build a fully functional localized token infrastructure in just days. With MotusAI, infrastructure teams can rapidly establish a private token system through a simple three-step process: deploying the local module, defining multi-dimensional quota and access policies, and integrating through standard developer interfaces. Once activated, MotusAI enables rapid developer onboarding while providing administrators with comprehensive control:

Developer Agility with “Zero-Wait” Access: Through unified URL aggregation, developers can instantly generate API keys and seamlessly switch between diverse models without rewriting code, accelerating the cycle from prototype to production. Real-time dashboards provide granular visibility that helps promote optimized prompting practices.

Precise Governance and Auditing: Administrators can enforce strict token quotas by department, project, or individual, ensuring premium compute resources are directed to core business priorities. With millisecond-level anomaly alerts and end-to-end local audit logs, MotusAI helps stop unauthorized usage in real time while providing data-driven insights for long-term resource planning.

Advanced Prefill-Decoding Separation: At the hardware layer, MotusAI implements an advanced Prefill-Decoding (P-D) separation architecture that decouples inference execution from scheduling. This technical innovation reduces raw hardware costs by 20% to 40%, increases throughput by 1.5x to 2.5x, and lowers latency by up to 60%, maximizing the efficiency of local GPU resources.

Conclusion

By shifting from scattered external API consumption to an optimized internal token platform built on MotusAI, high-volume enterprises can reduce annual token-related operating costs by 30% to 50%. For global businesses, MotusAI further lowers deployment barriers through native multilingual localization and local ISV ecosystem support tailored to competitive international markets, including Japan, South Korea, and Southeast Asia.

As tokens continue to emerge as the core operating currency of enterprise automation, KAYTUS provides the foundational infrastructure needed to reduce risk, optimize operations, and rapidly scale agentic AI worldwide.

About KAYTUS

KAYTUS is a leading provider of AI infrastructure and liquid cooling solutions, delivering a diverse range of innovative, open, and eco-friendly products for cloud, AI, edge computing, and other emerging applications. With a customer-centric approach, KAYTUS is agile and responsive to user needs through its adaptable business model. Discover more at KAYTUS.com and follow us on LinkedIn and X

View source version on businesswire.com: https://www.businesswire.com/news/home/20260604439673/en/

Contacts

Media Contacts
media@kaytus.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SLB Launches ExaCT Electrical Downhole CT Control System24.8.2026 13:02:00 CEST | Press Release

SLB (NYSE: SLB) today launched the ExaCT™ electrical downhole coiled tubing (CT) control system, an advanced intervention platform that introduces real-time electrical control to coiled tubing operations. By replacing pressure-dependent hydraulic actuation with electrical communication, power delivery and telemetry, the ExaCT system gives operators greater visibility, precision and control, helping improve intervention execution and reservoir access. The ExaCT system combines electrical power, telemetry and downhole measurements to enable communication with, actuation of and verification of downhole tools throughout an intervention. Continuous communication across the toolstring enables on-demand tool actuation across a wide range of intervention applications, including extended-reach and multilateral wells. The increased precision and control provided by the system help operators optimize reservoir access, improve production performance and maximize recovery. "Operators are asking int

Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI24.8.2026 13:01:00 CEST | Press Release

Wolters KluwerLegal & Regulatory today announced the next evolution of Libra by Wolters Kluwer, its all-in-one Legal AI Workspace. By transforming authoritative legal sources, expert commentaries, and practical guidance into structured legal intelligence, Wolters Kluwer is making the relationships across the full breadth of its expert legal sources more explicit. This will enable deeper contextual research, more comprehensible answers, and workflow-ready results across legal work. Following the integration of Wolters Kluwer content into the Libra AI workspace in the first half of 2026, laws, rulings, expert commentaries, and practical guidance will now be linked to one another and to the matter at hand, creating a connected knowledge graph of expert-curated and authoredlegal knowledge that AI can reason over. For customers, this means research that surfaces the right authority faster, answers with even clearer reasoning and sources, drafting guided by matter-specific context, and great

Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 10:00:00 CEST | Press Release

Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S

European Commission Approves DAYBU ® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 09:01:00 CEST | Press Release

Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim

ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 08:36:00 CEST | Press Release

Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly as possible. “Our discovery of the first orexin agonist is a successful representation of Japan-originated science that will directly impact people around the world living with narcolepsy type 1,” said Julie Kim, president and chief executive officer of Takeda. “With the potential to redefine narcolepsy type 1 care, ORZEYFUL is the first validation of our broader orexin strategy, demonstrating how scientifi

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye